Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies

Journal of the American Veterinary Medical Association

Volumn 228, Issue 10, 2006, Pages 1538-1545

  Treiber, Kibby H ^a   Kronfeld, David S ^a   Hess, Tanja M ^a   Byrd, Bridgett M ^a   Splan, Rebecca K ^a   Staniar, W Burton ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HYDROCORTISONE; INSULIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; CARBOHYDRATE INTAKE; COHORT ANALYSIS; DISEASE EXACERBATION; EVALUATION; FATTY ACID BLOOD LEVEL; FOOT DISEASE; GENETIC PREDISPOSITION; GENETIC RISK; GLUCOSE BLOOD LEVEL; HORSE DISEASE; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; INHERITANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LAMINITIS; METABOLIC SYNDROME X; METABOLISM; NON PARTICIPANT OBSERVATION; NONHUMAN; PASTURE; PEDIGREE; PENETRANCE; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMAL FEED; ANIMAL HUSBANDRY; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BLOOD GLUCOSE; COHORT STUDIES; DIETARY CARBOHYDRATES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HORSE DISEASES; HORSES; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; POACEAE; RISK FACTORS;

ANIMALIA; EQUIDAE;

EID: 33646589602     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.10.1538     Document Type: Article

References (55)

1. Neel JV. Diabetes mellitus: a thrifty genotype rendered detrimental by progress. Am J Human Gen 1962;14:353-362.
2. Brand-Miller JC, Colagirui S. Evolutionary aspects of diet and insulin resistance. World Rev Nutr Diet 1999;84:74-105.
3. Treiber KH, Boston RC, Kronfeld DS, et al. Insulin resistance and compensation in Thoroughbred weanlings adapted to high-glycemic meals. J Anim Sci 2005;83:2357-2364.
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
5. Adult Treatment Panel III. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. NIH Pub. No. 02-5215. Bethesda, Md: National Institutes of Health, 2002;1-284.
6. Jeffcott LB, Field JR. Current concepts of hyperlipaemia in horses and ponies. Vet Rec 1985;116:461-466.
7. Johnson PJ. The equine metabolic syndrome peripheral Cushings syndrome. Vet Clin North Am Equine Pract 2002;18:271-293.
8. USDA. Lameness and laminitis in U. S. horses. #N318.0400. Fort Collins, Colo: USDA, APHIS, VA, CEAH, National Animal Health Monitoring System, 2000.
9. Bailey SR, Marr CM, Elliott J. Current research and theories on the pathogenesis of acute laminitis in the horse. Vet J 2004;167:129-142.
10. Moore RM. Laminitis: steps in an on-going battle. Grayson-Jockey Club Research Today 2005;22:3-4.
11. Hood DM. The mechanisms and consequences of structural failure of the foot. Vet Clin North Am Equine Pract 1999;15:437-461.
12. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
13. Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J Am Vet Med Assoc 2005;226:712-719.
14. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-443.
15. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581.
16. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
17. Kerem N, Guttmann H, Hochberg Z. The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2. Horm Res 2001;55:298-304.
18. Henneke DR, Potter GD, Kreider JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
19. Reimers TJ, Cowan RG, McCann JP, et al. Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulin. Am J Vet Res 1982;43:1274-1278.
20. Alexander SL, Irvine CHG. The effect of social stress on adrenal axis activity in horses: the importance of monitoring corticosteroid-binding globulin capacity. J Endocrinol 1998;157:425-432.
21. Treiber KH, Kronfeld DS, Hess TM, et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005;66:2114-2121.
22. Gibson RS. Principles of nutritional assessment. New York: Oxford University Press, 1990.
23. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-809.
24. LaCasha PA, Brady HA, Allen VG, et al. Voluntary intake, digestibility, and subsequent selection of Matua bromegrass, coastal bermudagrass, and alfalfa hays by yearling horses. J Anim Sci 1999; 77:2766-2773.
25. Pearson RA, Archibald RF, Muirhead RH. The effect of forage quality and level of feeding oil digestibility and gastrointestinal transit time of oat straw and alfalfa given to ponies and donkeys. Br J Nutr 2001;85:599-606.
26. Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35:595-601.
27. Lindsay RS, Prochazka M, Baier LJ, et al. Currently identified genes affecting insulin resistance are not associated with birth weight in the Pima population. Diabetic Med 2002;19:881-886.
28. Alford P, Gellar S, Richardson B, et al. A multicenter, matched case-control study of risk factors for equine laminitis. Prev Vet Med 2001;49:209-222.
29. Dorn RC, Garner HE, Coffman JR, et al. Castration and other risk factors for equine laminitis. Prev Vet Med 1975;49:209-222.
30. Polzer J, Slater MR. Age, breed, sex and seasonality as risk factors for equine laminitis. Prev Vet Med 1996;29:179-184.
31. Junien C, Gallou-Kabani C, Vige A, et al. Nutritional epigenomics of metabolic syndrome. Med Sci 2005;21:396-404.
32. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred gelding. J Anim Sci 2003;81:2333-2342.
33. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003;144:2195-2200.
34. Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-229.
35. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236.
36. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000;49:883-888.
37. Abate N, Garg A, Reshock RM, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-1694.
38. Johnson PJ, Messer NT, Ganjam VK. Cushing's syndromes, insulin resistance and endocrinopathic laminitis. Equine Vet J 2004; 36:194-198.
39. Watson T. Equine hyperlipaemia. In: Watson T, ed. Metabolic and endocrine problems of the horse. London: WB Saunders Co, 1998; 23-40.
40. Bell AW, Bauman DE. Adaptations of glucose metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 1997;2:265-278.
41. Hoffman RM, Kronfeld DS, Cooper WL, et al. Glucose clearance in grazing mares is affected by diet, pregnancy, and lactation. J Anim Sci 2003;81:1764-1771.
42. Forhead AJ, Dobson H. Plasma glucose and cortisol responses to exogenous insulin in fasted donkeys. Vet Sci 1997;62:265-269.
43. Reeves HJ, Lees R, McGowan CM. Measurement of basal serum insulin concentrations in the diagnosis of Cushing's disease in ponies. Vet Rec 2001;149:449-452.
44. Beech J, Garcia M. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am J Vet Res 1985;46:1941-1943.
45. Donaldson MT, Jorgensen AJ, Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 2004;224:1123-1127.
46. Treiber KH, Hess TM, Kronfeld DS, et al. Insulin resistance and compensation in laminitis-predisposed ponies characterized by the minimal model. Pferdeheilkunde 2005;21:91-92.
47. Kyaw-Tanner M, Pollitt CC. Equine laminitis: increased transcription of matrix-metalloproteinase-2 (MMP-2) occurs during the development phase. Equine Vet J 2004;36:221-225.
48. Hinckley KA, Fearn S, Howard BR, et al. Nitric oxide donors as treatment for grass induced acute laminitis in ponies. Equine Vet J 1996;28:17-28.
49. Hood DM, Amoss MS, Hightower D, et al. Equine laminitis 1: radioisotopic analysis of the foot during the acute disease. Equine Laminitis 1978;2:439-444.
50. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J Clin Invest 1996;98:894-898.
51. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
52. Fonseca V, DeSouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 2004;25:153-175.
53. Juan C, Shen Y, Chien Y, et al. Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol 2004; 287:E948-E954.
54. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl 1999;26:133-138.
55. Mobasheri A, Critchlow K, Clegg PD, et al. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes. Equine Vet J 2004;36:248-254.